Bayer Settles Roundup Cancer Suits for Over $10 Billion
The deal will still allow Bayer to sell Roundup without adding any warnings, The New York Times reported.
It comes after three juries in early, high-profile trials awarded more
than $2.4 billion to plaintiffs who developed non-Hodgkin’s lymphoma
after long term Roundup use.